Equillium (EQ) Cash & Equivalents (2017 - 2026)

Equillium (EQ) has reported Cash & Equivalents for 10 consecutive years, with $61.3 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Cash & Equivalents rose 322.91% year-over-year to $61.3 million; the TTM figure through Mar 2026 stood at $61.3 million (up 322.91% YoY), while the FY2025 annual figure was $29.7 million, up 64.41% from the prior year.
• Cash & Equivalents advanced to $61.3 million in Q1 2026 per EQ's latest filing, from $29.7 million in the prior quarter.
• Across five years, Cash & Equivalents topped out at $61.3 million in Q1 2026 and bottomed at $10.3 million in Q2 2025.
• Historically, Cash & Equivalents has averaged $26.3 million across 5 years, with a median of $24.5 million in 2023.
• Annual changes were most pronounced in 2022 — Cash & Equivalents plunged 67.62% — and 2026, when it soared 322.91%.
• Equillium's Cash & Equivalents stood at $59.1 million in 2022, then sank by 60.72% to $23.2 million in 2023, then retreated by 22.1% to $18.1 million in 2024, then jumped by 64.41% to $29.7 million in 2025, then jumped by 106.24% to $61.3 million in 2026.
• Business Quant data shows EQ's Cash & Equivalents at $61.3 million in Q1 2026, $29.7 million in Q4 2025, and $33.1 million in Q3 2025.